Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print February 5, 2008
DOI: 10.2337/dc07-2433

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-2433v1
31/5/945    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, J. J.
Right arrow Articles by Mantzoros, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, J. J.
Right arrow Articles by Mantzoros, C. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Leptin does not directly regulate the pancreatic hormones, amylin and pancreatic polypeptide: interventional studies in humans

Janice J. Hwang, MD1, Jean L. Chan, MD1, Georgia Ntali, MD2, Dalia Malkova, MD3 and Christos S. Mantzoros, MD, DSc1

1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Department of Nutrition and Dietetics, Harokopio University, Athens, Greece
3Division of Developmental Medicine, Glasgow University, Glasgow, Scotland, UK

cmantzor{at}bidmc.harvard.edu

ABSTRACT

Objective: Leptin and the pancreatic hormones, amylin and pancreatic polypeptide (PP), are being evaluated alone or in combination for the treatment of obesity, but their physiological regulation has not yet been fully elucidated. Thus, we examined whether amylin and PP are regulated by caloric intake and/or short- and long-term energy deprivation and whether any potential regulation is mediated by changes in leptin levels.

Research Design and Methods: We measured circulating levels of amylin and PP after: 1) a 75-gram glucose load in 28 healthy, normal-weight women; 2) 72-hour complete energy deficiency (severe hypoleptinemia) with administration of either placebo or replacement-dose recombinant human leptin (r-metHuLeptin) in normal-weight men (n=6) and women (n=7); and 3) chronic mild energy deficiency (mild hypoleptinemia) in 7 women with hypothalamic amenorrhea (HA) before and after r-metHuLeptin administration for 3 months.

Results: Amylin and PP levels increased 15 minutes after a 75-gram glucose load and remained elevated at 60 and 120 minutes (P<0.0001). Fasting for 72 hours decreased leptin (to 21%) and amylin (to 67%) of baseline, but not PP levels. Normalizing leptin levels with r-metHuLeptin did not alter the fasting-induced decrease in amylin and had no effect on PP levels. Neither amylin nor PP levels were different in leptin-deficient HA women compared to weight-matched controls, and normalization of leptin levels with r-metHuLeptin treatment did not alter amylin or PP levels.

Conclusions: Circulating amylin levels increase after a glucose load and decrease in response to short-term complete fasting; but, these changes are not mediated by leptin.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.